Buys
Open market- Shares
- Avg price
- Total value
David P. Meeker - President and CEO, Director at RHYTHM PHARMACEUTICALS, INC.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- President and CEO, Director
- Issuer symbol
- RYTM on Nasdaq
- Source filings
- Open source filing history
Identity
2 facts
Issuer context
1 fact
SEC evidence
1 fact
David P. Meeker - trading volume in the past year for RHYTHM PHARMACEUTICALS, INC.
Sells
Open market- Shares
- -43,620
- Avg price
- $65.05
- Total value
- -$2,837,333
Net
Past year- Shares
- -43,620
- Share %
- -100%
- Total value
- -$2,837,333
Holdings reported by David P. Meeker for RHYTHM PHARMACEUTICALS, INC.
Form 4 holding
President and CEO, Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 239,016
- Estimated value
- $26,050,353
- Report date
- 01 Feb 2026
- Price
- $108.99
- Ownership
- Direct
Form 4 holding
President and CEO, Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 71,900
- Estimated value
- $3,647,775
- Report date
- 11 Feb 2026
- Price
- $57.22
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 107,850
- Estimated value
- Report date
- 11 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 03 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by David P. Meeker for RHYTHM PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.